week 1 Flashcards
name 5 drug properties which affect absorption in CV
MW
ionisation
solubility
formulation
liberation
name 3 patient related factors which affect absorption
route of administration
gastric pH
contents GIT
describe how malnutrition can affect drug volume of distribution
malnutrient leads to a decrease in albumin which increases the free drug volume and thus the volume of distribution of the drug increases
name 5 routes of elimination relating to CVD
pulmonary (expired in air)
bile (excreted in faeces)
renal- glomerular filtration, tubular reabsorption, tubular secretion
digoxin indication
heart failure
arterial fibrillation/ flutter
- doses should be reduced in the elderly
describe digoxins half life and VoD
T1/2= 26-45 hr
large VoD- it is extensively distributed in tissues
what does digoxin inhibit
Na/K ATPase enzyme
renin-angiotensin- aldosterone axis- what does it do
regulates BP
how does RAAS regulate BP (5)
modulates
- blood volume
- sodium reabsorption
- potassium secretion
- water reabsorption
- vascular tone
what is atherogenesis
Atherogenesis is the process of forming plaques in the intima layer of arteries.
how do we reduce atherogenesis
- reduce platelet adhesion
– we do this by using either aspirin (an irreversible cycloxygenase inhibitor) or clopidogrel (adenosine diphosphate receptor inhibitor)
these work by blocking thromboxane A2- which is essential in platelet aggregation
how does aspirin reduce platelet aggregation
aspirin works by blocking thromboxane A2- which is essential in platelet aggregation
how does clopidogrel reduce platelet aggregation
block the ADP (adenosine diphosphate) pathway and suppress its amplifying effect on platelet response
ADP- responsible for platelet aggregation
define efficacy
the degree to which a drug is able to produce the desired response
define potency
the amount of drug which is required to produce 50% of the maximal response which the drug is capable of inducing
- used to compare compounds within classes of drugs
define effective concentration
-ED50
the concentration of the drug which induces a specified clinical effect in 50% of subjects
define lethal dose
- LD50
the concentration if the drug which induced death in 50% of subjects
define therapeutic index
- measure of the safety of the drug
calculation - LD50/ED50
define margin of safety
margin between therapeutic and lethal doses
give 3 UV/Vis strengths
- easy, cheap, robust
- quantitative measurements of drugs in formulations
- routine methods to assess physio-chemical properties of drugs
give 3 UV/Vis limitations
- only moderately selective
- drug needs to have chromophore
- not really applicable to analysis of mixtures
define the terms in this equation A=abc
- beer-lambert law
A= absorption
a= absorptivity constant
b= pathlength = 1cm (just size of cuvette)
c= concentration
what are the 2 forms of absorptivity in the beer-lambert law
molar E
- absorbance of a 1mol/L solution in 1cm cell
- units= Lmol^-1cm^-1
specific
- absorbance of a 1g/100ml solution in 1cm cell
define the terms in this equation A=log10 (I0/I1)
where I0= light intensity transmitted
where I1= light intensity we can see
state the 2 ways of determining the concentration of an unknown solution
- use of literature A(1%, 1cm) or molar (E) values
– typically used when a pure standard is not available
– used in many BP assays - use of a calibration curve
– y=mx+c (notes symbols don’t mean the same here as they do in the beer-lambert law)
– for linear regression- rearrange equation for x (ie unknown concentration)
what stage is a BP of 120-139/ 80-89
prehypertensive
what stage is a BP of 140-159/90-99
stage one hypertensive
what stage is a BP of 160-179/ 100-109
stage two hypertensive
what stage is a BP of >180/>110
stage 3 hypertensive
define fibromuscular dysplasia
renovascular hypertension- happens when renal blood flow is compromised
more common in younger patients- esp female
relatively rare
what ethnicities are at higher risk of hypertension/ CVD
Asian
african
caribbean
what age do men become more at risk of hypertension/ CVD
55
what age do women become more at risk of hypertension/ CVD
65
name 3 consequences of left ventricle hypertrophy
(thickening of muscle wall)- caused by hypertension
- increase workload of LV
- increase after load of LV
- major risk factor for ischemic heart disease (myocardial infarction), arrhythmias, heart failure
CVS - hypertensive impacts (4)
- ventricular hypertrophy (thickening of muscle wall)
- arrhythmias
- coronary artery disease (acute MI)
- arterial aneurysm, dissection, rupture- fatal
kidney- hypertensive effects (3)
- glomerular sclerosis (leads to impaired kidney function and finally end stage kidney disease)
- reduction in GFR
- ischemic kidney disease- esp when renal artery stenosis is cause of hypertension (secondary)
long term kidney effects of hypertension (3)
- poor BP control
- reduced renal pressure (infrarenal redistribution of pressure and increase reabsorption of salt and water)
- decreased pressure in renal arterioles and sympathetic activity- renin production- angiotensin 2 production
name 2 effects of angiotensin 2 in the kidneys
- causes direct constriction of renal arterioles
- stimulation of aldosterone synthesis- sodium absorption and increase in intravascular blood volume
describe the importance of RAAS in blood pressure control
- activated in response to reduced blood flow
- this leads to decrease in GFR- which stimulates more angiotensin 2 and aldosterone- both of which raise BP
ARB
what does it stand for
example of drug
where does it work
- angiotensin 2 receptor inhibitors
- end in sartan
- act on AT1 receptors- found in heart, blood vessels, kidneys